معرفی
Shruti Sharma serves as an Associate Professor at Augusta University's Medical College of Georgia, holding joint appointments in the Department of Ophthalmology, the Center for Biotechnology and Genomic Medicine, the Culver Vision Discovery Institute, and the Department of Obstetrics and Gynecology. Her interdisciplinary research bridges genomic medicine, vision science, and metabolic disorders to address critical challenges in ocular pathology.
Her academic credentials include:
- Ph.D. in Botany/Plant Biology, University of Lucknow (2001)
- M.S. in Botany/Plant Biology, University of Lucknow (1995)
- B.S. in Botany/Plant Biology, University of Lucknow (1992)
Dr. Sharma's research program centers on diabetic retinopathy and dry eye disease pathogenesis, with deep investigation into IL-6 signaling pathways, oxidative stress mechanisms, and inflammatory processes in retinal endothelial cells and ocular surface tissues. She employs molecular, proteomic, and animal model approaches to identify therapeutic targets and diagnostic biomarkers for vision-threatening conditions.
Analysis of her 2023-2025 publications reveals a cohesive research trajectory focused on molecular mechanisms of diabetic complications in the eye, with significant contributions to understanding mitochondrial dysfunction in retinal cells, complement system involvement in glaucoma, and microRNA biomarkers in tear film. Her work consistently integrates genomic medicine principles with translational ophthalmology to address unmet clinical needs.
As an educator, Dr. Sharma teaches graduate courses including Investigation of a Problem in Genomic Medicine (GNMD 9210), Research in Genomic Medicine (GNMD 9300), Genomic Medicine Seminar (GNMD 8060), and Functional Genomics and Proteomics Using Animal Models (GNMD 8052), mentoring future genomic medicine researchers in diabetes and vision science applications.
Her laboratory operates within the Culver Vision Discovery Institute infrastructure, leveraging interdisciplinary collaborations across the Center for Biotechnology and Genomic Medicine to advance discovery from bench to bedside in vision-threatening diseases.
